16% cut from IPO price? Lenskart gets a ‘Sell’ from Ambit just before listing

Eyewear retailer Lenskart has received a “Sell” rating from Ambit Capital ahead of its IPO listing, with a target price of Rs 337—16% below the issue price of Rs 402. Ambit cited stretched valuations despite strong growth prospects, cautioning that free cash flows may remain negative until FY28 due to heavy capex plans.

LIC Q2 net rises 31% on business growth, higher margins

Life Insurance Corp, or LIC, saw its September quarter profit jump 31% to over ₹10,000 crore. This growth was fueled by its core business and improved margins. While premium growth faced a temporary dip due to GST benefits, LIC anticipates a strong second half. The company is focusing on profitable products and passing on GST […]

Sebi plans smoother IPO listings, rationalise offer documents

The Securities and Exchange Board of India (Sebi) is set to simplify IPO processes by reducing offer document summary content and streamlining procedures for companies with pre-IPO pledged shares. Chairman Tuhin Kanta Pandey stated these changes aim to encourage informed investor feedback and prevent listing delays.

Adani Enterprises to spread Rs 25,000-cr rights issue over 4 tranches

Adani Enterprises is set to launch its largest fundraising yet, a ₹25,000 crore rights issue. This will be spread over six to eight months in four tranches. The company plans to use a significant portion to repay loans from its promoters. This move will free up capital for future debt. The rights issue details are […]

Fortis, Siemens, Paytm and GE Vernova join MSCI India index

MSCI has updated its global indices. Fortis Healthcare, GE Vernova T&D India, Paytm, and Siemens Energy India are now part of the Global Standard Index. This move is expected to bring substantial investment into these stocks. Changes also affect the India Small Cap Index. Several companies will see their index weights adjusted, influencing fund movements.